Press Releases
NeurogesX to Pursue Expanded U.S Label for Qutenza(R) 8% Patch in HIV-Associated Neuropathy
NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced plans to pursue a U.S. label expansion for Qutenza(R)...
Press Releases
Italvacuum to Attend India CHEM 2010
We are pleased to announce that Italvacuum is participating India CHEM 2010, the largest event of the chemical and petrochemical industry in India....
Press Releases
APR and Labtec enter into exclusive License Agreement with Ferrer International
APR and its development partner Labtec have entered into an exclusive licensing agreement with the leading European pharmaceutical company Ferrer Internacional (Ferrer) for the promotion,...
Press Releases
Genzyme’s Alemtuzumab Shows Sustained Reduction in Relapses and Disability in Five-Year Review of MS Patients from Phase 2 Trial
Genzyme Corporation reported five-year patient data from its completed Phase 2 multiple sclerosis (MS) trial. This sub-group analysis found that nearly 90 percent of alemtuzumab-treated...
Press Releases
Weight Watchers and Merck Collaborate to Help Physicians Fight Obesity Through Lifestyle Management Approach
NEW YORK, NY and Whitehouse Station, NJ (October 13, 2010) – Weight Watchers International, Inc., the world's leading provider of weight management services, and Merck,...
Press Releases
Pfizer to Acquire King Pharmaceuticals, Inc.
Pfizer Inc.and King Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement. Under the terms of the agreement, Pfizer will acquire King,...
Press Releases
ImmunoGen, Inc. Announces Positive Interim Results in Randomized Clinical Trial
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the reporting of positive interim clinical data with trastuzumab-DM1 (T-DM1) for first-line...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.